Ivermectin Not Effective in Stopping Severe COVID, Study Finds

Feb. 22, 2022 — Ivermectin, the controversial anti-parasitic drug, does not help treat mild to moderate COVID-19, another new study has found.

“The study findings do not support the use of ivermectin for patients with COVID-19,” researchers said in the study published last week in JAMA Internal Medicine.

The trial took place at 20 public hospitals and a COVID-19 quarantine center in Malaysia between May 31 and Oct. 25.

Among 241 patients who received ivermectin, 52 developed severe COVID-19, compared to 43 of 249 patients who did not take the drug.

The people studied, who were on average 62 years old and were 55% women, were randomly assigned to receive either a 5-day course of ivermectin plus standard care or standard care alone.

No Difference by Vaccine Status

The researchers also looked at smaller groups of people in the study to see if there were differences in whether they were vaccinated. They said that analysis was “unremarkable.”

Just more than half of participants (51.8%) were fully vaccinated with two doses of COVID-19 vaccines. Among the vaccinated patients, 17.7% in the ivermectin group and 9.2% in the control group developed severe disease.

Ivermectin and COVID

While the FDA has not approved ivermectin to treat COVID-19, doctors continue to prescribe the inexpensive and widely available antiparasitic drug anyway. There is little evidence the drug is effective in treating COVID-19, but it has been embraced by anti-vaccine advocates as a useable alternative.

There have been reports of people becoming hospitalized after taking ivermectin, and the FDA has even warned against its use.

The authors of the new study acknowledge the controversy: “Although some early clinical studies suggested the potential efficacy of ivermectin in the treatment and prevention of COVID-19, these studies had methodologic weaknesses.”

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Edifecs completes acquisition of Health Fidelity thumbnail

Edifecs completes acquisition of Health Fidelity

Analytics company Edifecs announced Monday that it has finalized its acquisition of Health Fidelity, which specializes in risk-adjustment software for payers and providers. WHY IT MATTERS The deal, first announced in November, will bring Health Fidelity's analytics tools, developed to help risk-bearing organizations gain insights into care planning and enable more complete revenue capture, into…
Read More
PHR app DRiefcase connects with India's ABDM thumbnail

PHR app DRiefcase connects with India’s ABDM

India's National Health Authority has signed off the integration of DRiefcase, a mobile app for personal health records, with the Ayushman Bharat Digital Health Mission.  DRiefcase positions itself as a "health locker" app where users can store and access their medical records. It also offers a Scan at Home service that digitises users' paper health…
Read More
Biologics for CSU: When Is it Time to Try? thumbnail

Biologics for CSU: When Is it Time to Try?

Please enable cookies. Error 1005 Ray ID: 7904cdd20fac852b • 2023-01-27 22:07:55 UTC What happened? The owner of this website (www.webmd.com) has banned the autonomous system number (ASN) your IP address is in (47583) from accessing this website. Was this page helpful? Thank you for your feedback! Cloudflare Ray ID: 7904cdd20fac852b • Your IP: 217.21.81.33 •
Read More
Prof. Afek: Unvaccinated people should be charged higher health insurance premiums thumbnail

Prof. Afek: Unvaccinated people should be charged higher health insurance premiums

פרופ' ארנון אפק, לשעבר מנכ"ל משרד הבריאות וכיום משנה למנהל "שיבא", המשמש גם כחבר בקבינט המומחים למאבק בקורונה, מציע לחייב את הלא מחוסנים בדמי ביטוח בריאות גבוהים יותר וכן בביטוח רפואי מוגדל לשם נסיעה לחו"ל. פרופ' אפק הציג רעיון זה הבוקר (ב') במאמר דעה ב"ישראל היום" . "אם בתחילת גל התחלואה הנוכחי, הרביעי במספר, רוב…
Read More
Index Of News
Consider making some contribution to keep us going. We are donation based team who works to bring the best content to the readers. Every donation matters.
Donate Now

Subscription Form

Liking our Index Of News so far? Would you like to subscribe to receive news updates daily?

Total
0
Share